195 related articles for article (PubMed ID: 34889941)
1. Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression.
San Martin R; Das P; Dos Reis Marques R; Xu Y; Roberts JM; Sanders JT; Golloshi R; McCord RP
J Cell Biol; 2022 Feb; 221(2):. PubMed ID: 34889941
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.
Elemento O; Rubin MA; Rickman DS
Cell Cycle; 2012 Sep; 11(18):3380-3. PubMed ID: 22918253
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS2- driven ERG expression in vivo increases self-renewal and maintains expression in a castration resistant subpopulation.
Casey OM; Fang L; Hynes PG; Abou-Kheir WG; Martin PL; Tillman HS; Petrovics G; Awwad HO; Ward Y; Lake R; Zhang L; Kelly K
PLoS One; 2012; 7(7):e41668. PubMed ID: 22860005
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
5. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
Mehra R; Tomlins SA; Yu J; Cao X; Wang L; Menon A; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2008 May; 68(10):3584-90. PubMed ID: 18483239
[TBL] [Abstract][Full Text] [Related]
6. Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Sandoval GJ; Pulice JL; Pakula H; Schenone M; Takeda DY; Pop M; Boulay G; Williamson KE; McBride MJ; Pan J; St Pierre R; Hartman E; Garraway LA; Carr SA; Rivera MN; Li Z; Ronco L; Hahn WC; Kadoch C
Mol Cell; 2018 Aug; 71(4):554-566.e7. PubMed ID: 30078722
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.
Hermans KG; van Marion R; van Dekken H; Jenster G; van Weerden WM; Trapman J
Cancer Res; 2006 Nov; 66(22):10658-63. PubMed ID: 17108102
[TBL] [Abstract][Full Text] [Related]
8. A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancer.
Qu X; Randhawa G; Friedman C; O'Hara-Larrivee S; Kroeger K; Dumpit R; True L; Vakar-Lopez F; Porter C; Vessella R; Nelson P; Fang M
Cancer Genet; 2013; 206(1-2):1-11. PubMed ID: 23352841
[TBL] [Abstract][Full Text] [Related]
9. Retention of Interstitial Genes between
Murphy SJ; Kosari F; Karnes RJ; Nasir A; Johnson SH; Gaitatzes AG; Smadbeck JB; Rangel LJ; Vasmatzis G; Cheville JC
Cancer Res; 2017 Nov; 77(22):6157-6167. PubMed ID: 29127096
[No Abstract] [Full Text] [Related]
10. Induced chromosomal proximity and gene fusions in prostate cancer.
Mani RS; Tomlins SA; Callahan K; Ghosh A; Nyati MK; Varambally S; Palanisamy N; Chinnaiyan AM
Science; 2009 Nov; 326(5957):1230. PubMed ID: 19933109
[TBL] [Abstract][Full Text] [Related]
11. A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumors.
Qu X; Randhawa G; Friedman C; Kurland BF; Glaskova L; Coleman I; Mostaghel E; Higano CS; Porter C; Vessella R; Nelson PS; Fang M
PLoS One; 2013; 8(9):e74671. PubMed ID: 24098661
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients.
Holcomb IN; Grove DI; Kinnunen M; Friedman CL; Gallaher IS; Morgan TM; Sather CL; Delrow JJ; Nelson PS; Lange PH; Ellis WJ; True LD; Young JM; Hsu L; Trask BJ; Vessella RL
Cancer Res; 2008 Jul; 68(14):5599-608. PubMed ID: 18632612
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin.
Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M
Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model.
Leshem O; Madar S; Kogan-Sakin I; Kamer I; Goldstein I; Brosh R; Cohen Y; Jacob-Hirsch J; Ehrlich M; Ben-Sasson S; Goldfinger N; Loewenthal R; Gazit E; Rotter V; Berger R
PLoS One; 2011; 6(7):e21650. PubMed ID: 21747944
[TBL] [Abstract][Full Text] [Related]
15. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy.
Gopalan A; Leversha MA; Satagopan JM; Zhou Q; Al-Ahmadie HA; Fine SW; Eastham JA; Scardino PT; Scher HI; Tickoo SK; Reuter VE; Gerald WL
Cancer Res; 2009 Feb; 69(4):1400-6. PubMed ID: 19190343
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.
Mertz KD; Setlur SR; Dhanasekaran SM; Demichelis F; Perner S; Tomlins S; Tchinda J; Laxman B; Vessella RL; Beroukhim R; Lee C; Chinnaiyan AM; Rubin MA
Neoplasia; 2007 Mar; 9(3):200-6. PubMed ID: 17401460
[TBL] [Abstract][Full Text] [Related]
17. Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer.
Ulz P; Belic J; Graf R; Auer M; Lafer I; Fischereder K; Webersinke G; Pummer K; Augustin H; Pichler M; Hoefler G; Bauernhofer T; Geigl JB; Heitzer E; Speicher MR
Nat Commun; 2016 Jun; 7():12008. PubMed ID: 27328849
[TBL] [Abstract][Full Text] [Related]
18. Morphological features of TMPRSS2-ERG gene fusion prostate cancer.
Mosquera JM; Perner S; Demichelis F; Kim R; Hofer MD; Mertz KD; Paris PL; Simko J; Collins C; Bismar TA; Chinnaiyan AM; Rubin MA
J Pathol; 2007 May; 212(1):91-101. PubMed ID: 17385188
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
Swanson TA; Krueger SA; Galoforo S; Thibodeau BJ; Martinez AA; Wilson GD; Marples B
Prostate; 2011 Oct; 71(14):1548-58. PubMed ID: 21394739
[TBL] [Abstract][Full Text] [Related]
20. Analysis, Modeling, and Visualization of Chromosome Conformation Capture Experiments.
Di Stefano M; Castillo D; Serra F; Farabella I; Goodstadt MN; Marti-Renom MA
Methods Mol Biol; 2021; 2157():35-63. PubMed ID: 32820398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]